Lack of CpG Island Methylator Phenotype Defines a Clinical Subtype of T-Cell Acute Lymphoblastic Leukemia Associated With Good Prognosis

Abstract

Our results suggest that the methylation profile may be a potential new biomarker of risk prediction in T-ALL.